Published in Brain Res on August 04, 1987
Direct coupling of opioid receptors to both stimulatory and inhibitory guanine nucleotide-binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells. Proc Natl Acad Sci U S A (1993) 0.96
Reconstitution of high-affinity opioid agonist binding in brain membranes. Proc Natl Acad Sci U S A (1991) 0.77
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂. Pharmacol Rev (2010) 4.31
Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol (2000) 2.95
Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther (1996) 2.90
Simultaneous quantitative assessment of morphine tolerance and physical dependence. J Pharmacol Exp Ther (1969) 2.78
Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J Neurosci (1995) 2.62
beta-endorphin is a potent analgesic agent. Proc Natl Acad Sci U S A (1976) 2.30
Synthesis and analgesic activity of human beta-endorphin. J Med Chem (1977) 1.98
Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br J Pharmacol (1996) 1.75
3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor. Bioorg Med Chem (1999) 1.73
Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding. Drug Alcohol Depend (2000) 1.55
Functional homology between signal-coupling proteins. Cholera toxin inactivates the GTPase activity of transducin. J Biol Chem (1982) 1.53
Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor. J Pharmacol Exp Ther (2000) 1.52
U73122 inhibits phospholipase C-dependent calcium mobilization in neuronal cells. Brain Res (1994) 1.48
Phosphorylation of Ser363, Thr370, and Ser375 residues within the carboxyl tail differentially regulates mu-opioid receptor internalization. J Biol Chem (2001) 1.46
Beta-Endorphin as a potent analgesic by intravenous injection. Nature (1976) 1.40
Lectins: endogenous carbohydrate-binding proteins from vertebrate tissues: functional role in recognition processes? Life Sci (1978) 1.37
Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene. Proc Natl Acad Sci U S A (1994) 1.34
Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5'-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes. J Pharmacol Exp Ther (1998) 1.31
Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol Pharmacol (1992) 1.30
Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system. Eur J Pharmacol (1999) 1.30
Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice. J Pharmacol Exp Ther (2001) 1.27
The kappa-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids. Proc Natl Acad Sci U S A (1995) 1.25
Cyclic adenosine monophosphate antagonism of morphine analgesia. J Pharmacol Exp Ther (1973) 1.23
Insights into the receptor transcription and signaling: implications in opioid tolerance and dependence. Neuropharmacology (2004) 1.22
Regulation of opioid receptor activities. J Pharmacol Exp Ther (1999) 1.22
Receptor density and recycling affect the rate of agonist-induced desensitization of mu-opioid receptor. Mol Pharmacol (2000) 1.22
beta-Endorphin: structure-activity relationships in the guinea pig ileum and opiate receptor binding assays. Biochem Biophys Res Commun (1977) 1.20
The bioactive conformation of aminoalkylindoles at the cannabinoid CB1 and CB2 receptors: insights gained from (E)- and (Z)-naphthylidene indenes. J Med Chem (1998) 1.20
Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor. J Med Chem (1996) 1.19
delta-Opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin. J Neurosci (1995) 1.19
Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned mu, delta, and kappa opioid receptors. Brain Res Mol Brain Res (1994) 1.16
Mutation of a highly conserved aspartate residue in the second transmembrane domain of the cannabinoid receptors, CB1 and CB2, disrupts G-protein coupling. J Pharmacol Exp Ther (1998) 1.16
Effects of opioids on the immune system. Neurochem Res (1996) 1.16
Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system. J Pharmacol Exp Ther (1999) 1.15
Developmentally regulated lectin in neonatal rat brain. Nature (1977) 1.13
Deltorphin II-induced rapid desensitization of delta-opioid receptor requires both phosphorylation and internalization of the receptor. J Biol Chem (2000) 1.10
Expression of alternate forms of brain opioid 'orphan' receptor mRNA in activated human peripheral blood lymphocytes and lymphocytic cell lines. Brain Res Mol Brain Res (1995) 1.10
Molecular characterization of a new immunoglobulin superfamily protein with potential roles in opioid binding and cell contact. EMBO J (1989) 1.09
Pharmacological manipulation of gamma-aminobutyric acid (GABA) in morphine analgesia, tolerance and physical dependence. Life Sci (1976) 1.08
Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. J Pharmacol Exp Ther (1998) 1.08
3H-Leu5-enkephalin specific binding to synaptic membrane-comparison with 3H-dihydromorphine and 3H-naloxone. Res Commun Chem Pathol Pharmacol (1978) 1.08
Transcriptional regulation of mouse mu-opioid receptor gene. J Biol Chem (1998) 1.06
Effects of acute and chronic morphine treatments on calcium localization and binding in brain. J Pharmacol Exp Ther (1978) 1.06
Molecular cloning of a novel protein regulated by opioid treatment of NG108-15 cells. Brain Res Mol Brain Res (1995) 1.06
MU-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions. Brain Res Mol Brain Res (1998) 1.06
Dual promoters of mouse mu-opioid receptor gene. Biochem Biophys Res Commun (1997) 1.05
mu-Opioid receptor-knockout mice: the role of mu-opioid receptor in gastrointestinal transit. Brain Res Mol Brain Res (1998) 1.04
Single-stranded DNA-binding complex involved in transcriptional regulation of mouse mu-opioid receptor gene. J Biol Chem (2001) 1.04
Unique behavioral effects of beta endorphin and their relationship to thermoregulation and hypothalamic function. Life Sci (1978) 1.03
Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells. Mol Pharmacol (1992) 1.03
Effects of withdrawal from chronic amphetamine intoxication on exploratory and stereotyped behaviors in the rat. Psychopharmacology (Berl) (1977) 1.03
Hierarchical phosphorylation of delta-opioid receptor regulates agonist-induced receptor desensitization and internalization. J Biol Chem (2000) 1.03
Expression of the mu-opioid receptor in CHO cells: ability of mu-opioid ligands to promote alpha-azidoanilido[32P]GTP labeling of multiple G protein alpha subunits. J Neurochem (1995) 1.02
Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins. Mol Pharmacol (1994) 1.01
Ethanol-induced fluidization of brain lipid bilayers: required presence of cholesterol in membranes for the expression of tolerance. Mol Pharmacol (1979) 1.00
An investigation into the structural determinants of cannabinoid receptor ligand efficacy. Br J Pharmacol (1999) 1.00
Morphine tolerance, physical dependence, and synthesis of brain 5-hydroxytryptamine. Science (1968) 1.00
Loss of opiate receptor activity in neuroblastoma X glioma NG108-15 hybrid cells after chronic opiate treatment. A multiple-step process. Mol Pharmacol (1982) 1.00
Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes. Mol Pharmacol (1983) 1.00
Quantitative aspects of precipitated abstinence in morphine-dependent rats. J Pharmacol Exp Ther (1973) 1.00
Role of a conserved lysine residue in the peripheral cannabinoid receptor (CB2): evidence for subtype specificity. Mol Pharmacol (1999) 0.99
Opiate and peptide interaction: effect of enkephalins on morphine analgesia. Eur J Pharmacol (1980) 0.98
Endorphins may function in heat adaptation. Proc Natl Acad Sci U S A (1978) 0.98
A protein-lipid model of the opiate receptor. Life Sci (1980) 0.98
Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists. Proc Natl Acad Sci U S A (1996) 0.98
Down-regulation of opiate receptor in neuroblastoma x glioma NG108-15 hybrid cells. Chloroquine promotes accumulation of tritiated enkephalin in the lysosomes. J Biol Chem (1984) 0.97
Opioids mobilize calcium from inositol 1,4,5-trisphosphate-sensitive stores in NG108-15 cells. J Neurosci (1994) 0.97
Brain serotonin turnover in morphine tolerant and dependent mice. J Pharmacol Exp Ther (1970) 0.97
Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment. J Pharmacol Exp Ther (1987) 0.97
Brain sites of precipitated abstinence in morphine-dependent rats. J Pharmacol Exp Ther (1973) 0.97
The effect of nicotinamide and homologs on the activity of inducible enzymes and NAD content of the rat liver. Mol Pharmacol (1967) 0.96
dsAAV type 2-mediated gene transfer of MORS196A-EGFP into spinal cord as a pain management paradigm. Proc Natl Acad Sci U S A (2007) 0.96
Ability of delta-opioid receptors to interact with multiple G-proteins is independent of receptor density. J Biol Chem (1994) 0.95
The absence of a direct correlation between the loss of [D-Ala2, MePhe4,Gly5-ol]Enkephalin inhibition of adenylyl cyclase activity and agonist-induced mu-opioid receptor phosphorylation. J Biol Chem (1999) 0.94
beta-Endorphin in vitro inhibition of striatal dopamine release. Nature (1976) 0.94
Demonstration and characterization of opiate inhibition of the striatal adenylate cyclase. J Neurochem (1981) 0.94
The mu-opioid receptor down-regulates differently from the delta-opioid receptor: requirement of a high affinity receptor/G protein complex formation. Mol Pharmacol (1997) 0.94
Cannabinoid receptors in developing rats: detection of mRNA and receptor binding. Drug Alcohol Depend (1994) 0.93
Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions. J Pharmacol Exp Ther (1976) 0.93
Dynorphin interaction at the kappa-opiate site. Eur J Pharmacol (1981) 0.93
Properties and localization of beta-endorphin receptor in rat brain. Proc Natl Acad Sci U S A (1979) 0.93
Comparison of the effects of morphine on locomotor activity, analgesia and primary and protracted physical dependence in six mouse strains. J Pharmacol Exp Ther (1977) 0.93
Effects of divalent cations, cation chelators and an ionophore on morphine analgesia and tolerance. J Pharmacol Exp Ther (1975) 0.92
Mutational analysis of the structure and function of opioid receptors. Biopolymers (1999) 0.92
Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages. Biochem Biophys Res Commun (1995) 0.92
Cloning, sequencing and localization to chromosome 11 of a cDNA encoding a human opioid-binding cell adhesion molecule (OBCAM). Gene (1995) 0.92
Purification to apparent homogeneity of a mu-type opioid receptor from rat brain. Proc Natl Acad Sci U S A (1986) 0.91
Visualization of time-dependent redistribution of delta-opioid receptors in neuronal cells during prolonged agonist exposure. Brain Res Mol Brain Res (1999) 0.91
Discrete changes in brain calcium with morphine analgesia, tolerance-dependence, and abstinence. Life Sci (1977) 0.91
Effects of clonidine on morphine withdrawal signs in the rat. Eur J Pharmacol (1975) 0.90
Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma x glioma hybrid NG108-15 cells. Mol Pharmacol (1992) 0.90
Transcriptional modulation of mouse mu-opioid receptor distal promoter activity by Sox18. Mol Pharmacol (2001) 0.90
Deficient activity of receptor-cyclase coupling protein is transformed lymphoblasts of patients with pseudohypoparathyroidism, type I. J Clin Endocrinol Metab (1982) 0.90
Regulation of mouse kappa opioid receptor gene expression by retinoids. J Neurosci (2001) 0.90